Breast cancer-specific survival by molecular subtype in different age groups of women in Scotland
Age influences BC-specific mortality particularly within luminal subtypes. In contrast, other tumour characteristics and treatment are key prognostic factors for non-luminal subtypes. Future studies should investigate other markers of BC mortality particularly among over 70-year-olds, who account for 60% of BC deaths in the UK.
Authors
- Jonine D. Figueroa (ORCID: https://orcid.org/0000-0002-5100-623X)
- Sheila M. Bird (ORCID: https://orcid.org/0000-0001-6378-8382)
- Peter S Hall (ORCID: https://orcid.org/0000-0001-6015-7841)
- Kai Jin (ORCID: https://orcid.org/0000-0002-4071-7415)
- David Brewster (ORCID: https://orcid.org/0000-0002-5346-5608)
- Sarah H. Wild (ORCID: https://orcid.org/0000-0001-7824-2569)
- Ines Mesa‐Eguiagaray (ORCID: https://orcid.org/0000-0002-6784-2419)
- Linda Williams (ORCID: https://orcid.org/0000-0002-6317-1718)
Institutions
- The University of Sydney (AU)
- Edinburgh Cancer Research (GB)
- MRC Biostatistics Unit (GB)
- National Cancer Institute (US)
- University of Edinburgh (GB)
Publication Details
- Journal
- Breast Cancer Research
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1186/s13058-025-02012-x
- Citations
- 3
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.81
Funders
- Wellcome Trust
- NHS Health Scotland
- National Institutes of Health
- National Cancer Institute
- Division of Cancer Epidemiology and Genetics, National Cancer Institute